Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2441105
Max Phase: Preclinical
Molecular Formula: C19H15NO4
Molecular Weight: 321.33
Molecule Type: Small molecule
Associated Items:
ID: ALA2441105
Max Phase: Preclinical
Molecular Formula: C19H15NO4
Molecular Weight: 321.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1ccc(Oc2ccc(O)cc2)cc1)c1ccccc1O
Standard InChI: InChI=1S/C19H15NO4/c21-14-7-11-16(12-8-14)24-15-9-5-13(6-10-15)20-19(23)17-3-1-2-4-18(17)22/h1-12,21-22H,(H,20,23)
Standard InChI Key: RBEMVAFKFYHQIB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 321.33 | Molecular Weight (Monoisotopic): 321.1001 | AlogP: 4.14 | #Rotatable Bonds: 4 |
Polar Surface Area: 78.79 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.92 | CX Basic pKa: | CX LogP: 3.96 | CX LogD: 3.84 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.67 | Np Likeness Score: -0.63 |
1. Yamada A, Fujii S, Mori S, Kagechika H.. (2013) Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists., 4 (10): [PMID:24900588] [10.1021/ml4001744] |
Source(1):